Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (141-150 of 200) with videos related to

Pageof 20
Sort By:
European Heart Journal|December 17, 2021
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattia Galli, Stefano Benenati, Francesco Franchi, et al.
Journal of Thrombosis and Thrombolysis|February 11, 2019
Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trialLukasz Koltowski, Mariusz Tomaniak, Lisa Gross, et al.
Thrombosis and Haemostasis|June 22, 2019
Gender and Outcomes following Guided De-Escalation of Antiplatelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Gender SubstudyLisa Gross, Danny Kupka, Dietmar Trenk, et al.
JACC. Cardiovascular Interventions|October 9, 2020
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes MellitusGjin Ndrepepa, Adnan Kastrati, Maurizio Menichelli, et al.
European Heart Journal|December 8, 2022
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on ThrombosisFelicita Andreotti, Tobias Geisler, Jean-Philippe Collet, et al.
European Heart Journal|April 6, 2021
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart DiseaseJurrien Ten Berg, Dirk Sibbing, Bianca Rocca, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 24, 2022
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm SocietyDiana A Gorog, Ying X Gue, Tze-Fan Chao, et al.
European Heart Journal|June 19, 2018
Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trialDirk Sibbing, Lisa Gross, Dietmar Trenk, et al.
Thrombosis and Haemostasis|July 6, 2022
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus PaperDiana A Gorog, Ying X Gue, Tze-Fan Chao, et al.
Platelets|May 4, 2021
ADP-induced platelet reactivity and bleeding events in patients with acute myocardial infarction complicated by cardiogenic shockClemens Scherer, Enzo Lüsebrink, Danny Kupka, et al.
Pageof 20

Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
European Heart Journal|December 17, 2021
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattia Galli, Stefano Benenati, Francesco Franchi, et al.
Journal of Thrombosis and Thrombolysis|February 11, 2019
Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trialLukasz Koltowski, Mariusz Tomaniak, Lisa Gross, et al.
Thrombosis and Haemostasis|June 22, 2019
Gender and Outcomes following Guided De-Escalation of Antiplatelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Gender SubstudyLisa Gross, Danny Kupka, Dietmar Trenk, et al.
JACC. Cardiovascular Interventions|October 9, 2020
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndromes and Diabetes MellitusGjin Ndrepepa, Adnan Kastrati, Maurizio Menichelli, et al.
European Heart Journal|December 8, 2022
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on ThrombosisFelicita Andreotti, Tobias Geisler, Jean-Philippe Collet, et al.
European Heart Journal|April 6, 2021
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart DiseaseJurrien Ten Berg, Dirk Sibbing, Bianca Rocca, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 24, 2022
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm SocietyDiana A Gorog, Ying X Gue, Tze-Fan Chao, et al.
European Heart Journal|June 19, 2018
Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trialDirk Sibbing, Lisa Gross, Dietmar Trenk, et al.
Thrombosis and Haemostasis|July 6, 2022
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus PaperDiana A Gorog, Ying X Gue, Tze-Fan Chao, et al.
Platelets|May 4, 2021
ADP-induced platelet reactivity and bleeding events in patients with acute myocardial infarction complicated by cardiogenic shockClemens Scherer, Enzo Lüsebrink, Danny Kupka, et al.
Pageof 20